Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index |
Title: |
Botulinum Toxin Type A for |
|
Introduction: The use of botulinum
toxin type A (BoNT-A) as a preventive headache treatment is
increasing but remains controversial and the subject of much
discussion. Several factors contribute to this discussion,
the most important of which is the question of the evidence of
its efficacy in headache prevention. The limited number of
conclusive placebo-controlled trials has led to the challenge
that the data do not differentiate a genuine treatment effect
from a placebo response. Without doubt, an intensive neurologic
consultation involving muscle palpation and injection of a
high-profile treatment inevitably will create some element of
placebo response. Questions also arise as to how the
muscle-relaxing effects of BoNT-A could be relevant to the
pathophysiology of migraine. To confound matters further,
the cost of BoNT-A therapy is relatively high.
|
Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index
Copyright © 2002- Lawrence Robbins, MD
All Rights Reserved.
This site is maintained by MICE Training & Technology™ Web Design
Contact: